DRUG
carborane-containing bioisostere of erlotinib
1 hypothesis across 1 therapeutic domain
ALL HYPOTHESES
Repurposing candidates for carborane-containing bioisostere of erlotinib
Pancreatic cancer 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| EGFR | pancreatic ductal adenocarcinoma | 0.208 | Mid | unknown | unknown |
Clinical trials
0 registered trials for carborane-containing bioisostere of erlotinib
Source: ClinicalTrials.gov
No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.
Search ClinicalTrials.gov →